ArticleThe Lancet. Global health2024

Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis.

Theresa S Ryckman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.